Craneware PLC
LSE:CRW
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1 620
2 470
|
Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Craneware PLC
Note Receivable
Craneware PLC
Note Receivable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Note Receivable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Craneware PLC
LSE:CRW
|
Note Receivable
$3.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
7%
|
||
Renalytix PLC
LSE:RENX
|
Note Receivable
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Cambridge Cognition Holdings PLC
LSE:COG
|
Note Receivable
ÂŁ20k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Intelligent Ultrasound Group PLC
LSE:IUG
|
Note Receivable
ÂŁ61k
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
EMIS Group PLC
LSE:EMIS
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Doctor Care Anywhere Group PLC
ASX:DOC
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Craneware PLC
Glance View
Craneware Plc engages in the provision of software and support services for the healthcare industry. The firm's Value Cycle Solutions has five product families, which include Patient Engagement, Charge Capture & Pricing, Claims Analytics, Cost and Margin Analytics, and Revenue Recovery & Retention. Its Patient Engagement solutions include InSight Medical Necessity, which provides access to medical necessity and prior authorization policies for Medicare, Medicare supplements and commercial payors impacting customers facility. Its Charge Capture & Pricing solution include Chargemaster Toolkit, Trisus Pricing Transparency, Trisus Pharmacy Financial Management, Trisus Pricing Analyzer, Online Reference Toolkit, and others. Its Claims Analytics solution include Trisus Claims Informatics. Its Revenue Recovery & Retention solution include InSight Denials, InSight Audit and Appeals Services.
See Also
What is Craneware PLC's Note Receivable?
Note Receivable
3.6m
USD
Based on the financial report for Jun 30, 2024, Craneware PLC's Note Receivable amounts to 3.6m USD.
What is Craneware PLC's Note Receivable growth rate?
Note Receivable CAGR 10Y
7%
Over the last year, the Note Receivable growth was 32%.